Chronic Kidney Failure in Children and Young Adults research hub

Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

This study looks at a new treatment called dapagliflozin for young people (aged 10-39) with Alport syndrome, a type of chronic kidney disease. It aims to see if this medicine can slow down kidney damage and improve their quality of life.